We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
Behind the science
168幸运飞行艇官方开奖结果官网2023-幸运168飞艇官网现场开奖直播视频-168飞艇官网开奖历史记录查询 Discover how we're getting ahead
‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development
Fresh insights could finally help us tackle RSV
‘I had never experienced anything like it’: the pain, risks, and first symptoms of shingles every adult should know
Age-related decline in immunity: why does it matter and what can be done about it?
‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women
AI and ML power better predictions for patient impact
Digital twin: using advanced technology to accelerate vaccine development
The ‘tripledemic’ will hit older people hard this winter – but there are things we can all do to reduce the impact
Life at GSK
How we help people thrive
Diversity, equity and inclusion
168飞艇官网现场开奖直播-168极速赛车官网开奖历史记录-幸运168飞艇开奖结果官网 Positively impacting society and the planet
We are making our products affordable and available to more people around the world through responsible pricing, strategic access programmes and partnerships.
Global health and health security
We are committed to using our science, our partnerships, and the knowledge we’ve gained from addressing the world’s biggest health challenges to improve health globally.
We're committed to work towards a net zero, nature positive, healthier planet, with ambitious goals set for 2030 and 2045.
Diversity, equity and inclusion
Our work supports the health of all kinds of people. To meet our diverse patients' needs better, we need diversity in our clinical trials and to support our own people to thrive as part of an inclusive team.
Our culture guides our people to do the right thing and act on any concerns they have.
Ensuring the quality, safety and reliable supply of our products is critical to our purpose of uniting science, talent and technology to get ahead of disease together.
In the spotlight
GSK on social
Twitter @GSK Apr 19
Every medicine that leaves GSK and reaches a patient goes through our Medicine Development and Supply team. Learn how our dedicated MDS team are getting ahead of disease together. #AheadTogetherTwitter @GSK Apr 18
#News for #investors and #media: Today we announced the proposed acquisition of @BELLUSHealth, a clinical stage biopharmaceutical company that further strengthens our specialty medicines and respiratory pipeline. Find out more: gsk.to/40jdUj1Twitter @GSK Apr 18
Did you know that the immune system becomes less effective in defending us from infectious diseases like #shingles as we age? Go Behind the Science and learn more about age-related decline in immunity: gsk.to/40fMn1Z #ECCMID2023Twitter @GSK Apr 17
Twitter @GSK Apr 15
Great recognition of our partnership with @DDU_Dundee. We've been working together since 2011 to develop much needed drug candidates for Neglected Tropical Diseases #AheadTogether #BiochemAwards twitter.com/DDU_Dundee/sta…Twitter @GSK Apr 12
This week we will be at #ECCMID2023 alongside medical experts to discuss the latest developments in #infectiousdiseases and share our expertise across treatment and prevention. Learn more about how we’re getting ahead of infectious diseasesTwitter @GSK Apr 11
Meet our 2023 #GSKIMPACTUK Award winner @StreetDoctors, empowering young people affected by street violence with emergency lifesaving skills and knowledge about the consequences of violence, to keep themselves and their communities safe. Find out more 👉streetdoctors.org9oTwitter @GSK Apr 08
Twitter @GSK Apr 08
Meet our 2023 #GSKIMPACTUK Award winner @RRR_LUF, improving individual lives, building resilience, empowering service user voice, and creating stronger, better-connected families and communities. Learn more: redroserecovery.org.ukTwitter @GSK Apr 07